Related Experiment Video
Updated: Aug 11, 2026
07:48
Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
Regulations governing drug trials in Turkey
1Faculty of Medicine, Department of Medical Ethics and History, Hacettepe University, Ankara, Turkey.
Medicine and Law
|June 18, 2003
Summary
Ethical challenges in human drug trials are increasing due to industry demands. Turkey
Area of Science:
- Medical ethics
- Clinical research
- Pharmacology
Background:
- Ethical considerations in human subject research are complex.
- The pharmaceutical industry's growth presents new challenges for drug trials.
- Increasing clinical trial activity necessitates robust ethical oversight.
Purpose of the Study:
- To examine the ethical landscape of human drug trials.
- To highlight the challenges faced by investigators in this field.
- To assess the regulatory environment in Turkey regarding drug trials.
Main Methods:
- Review of ethical guidelines and legal frameworks.
- Analysis of trends in clinical trial conduct.
- Case study of regulatory progress in Turkey.
Main Results:
- Investigator challenges in human drug trials are significant.
- The pharmaceutical industry's influence complicates ethical oversight.
- Turkey shows progressive legal provisions for drug trials.
Conclusions:
- Ethical issues in drug trials require ongoing attention.
- Legal frameworks are evolving to better protect human subjects.
- Improvements focus on trial design and volunteer safety in Turkey.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...